Y-Intercept (HK)’s Revolution Medicines RVMD Stock Holding History

Y-Intercept (HK)’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$783K	Buy	+3,815	New	+$756K	0.02%	1114
2025 Q4	–	Sell	-55,323	Closed	-$2.58M	–	1932
2025 Q3	$2.58M	Sell	55,323 -43,581	-44%	-$1.71M	0.06%	472
2025 Q2	$3.64M	Buy	+98,904	New	+$3.8M	0.09%	339
2024 Q4	–	Sell	-5,444	Closed	-$247K	–	1593
2024 Q3	$247K	Buy	+5,444	New	+$237K	0.02%	1084
2024 Q2	–	Sell	-13,889	Closed	-$448K	–	1847
2024 Q1	$448K	Buy	+13,889	New	+$412K	0.03%	769
2023 Q4	–	Sell	-31,065	Closed	-$860K	–	1594
2023 Q3	$860K	Buy	+31,065	New	+$921K	0.08%	361

Other funds holding RVMD

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Y-Intercept (HK)'s RVMD Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Revolution Medicines (RVMD) in Q3 2026: 3,815 shares worth $783K. The stake represents 0.02% of the portfolio and ranks #1114 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in RVMD as recently as Q3 2025.

Y-Intercept (HK) first reported a position in RVMD in Q3 2023 and has held it in 6 quarters since. The position peaked at $3.64M in Q2 2025. 405 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

Y-Intercept (HK) held 3,815 shares of Revolution Medicines worth $783K as of Q3 2026.
Revolution Medicines was a new Y-Intercept (HK) position in Q3 2026.
Revolution Medicines made up 0.02% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1114 holding.
Y-Intercept (HK) first reported a position in Revolution Medicines in Q3 2023 and has held it in 6 quarters since.
Y-Intercept (HK)'s Revolution Medicines position peaked at $3.64M in Q2 2025.
405 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.